Berberine regulates pulmonary inflammatory microenvironment and decreases collagen deposition in response to bleomycin‐induced pulmonary fibrosis in mice-Reference-Cited by-同舟云学术

Berberine regulates pulmonary inflammatory microenvironment and decreases collagen deposition in response to bleomycin‐induced pulmonary fibrosis in mice

Published:2022-12-14 Issue:2 Volume:132 Page:154-170
ISSN:1742-7835
Container-title:Basic & Clinical Pharmacology & Toxicology
language:en
Short-container-title:Basic Clin Pharma Tox

Author:

Yang Zheng¹,Bian Mengni²³,Ma Junbing¹,Dong Yonghe²,Yang Dan²,Qiu Min²^ORCID,Gao Zhixiang²

Affiliation:

1. Department of Cardiovascular Diseases First Affiliated Hospital of Baotou Medical College Baotou China

2. Department of Pharmacy Baotou Medical College Baotou China

3. Department of Clinical Pharmacy Third Affiliated Hospital of Inner Mongolia Medical University Baotou China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Inner Mongolia

Publisher

Wiley

Subject

Pharmacology,Toxicology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcpt.13818

Reference40 articles.

1. Existing and emerging biomarkers for disease progression in idiopathic pulmonary fibrosis

2. Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review

3. Exploring Animal Models That Resemble Idiopathic Pulmonary Fibrosis

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Carbon monoxide attenuates cellular senescence-mediated pulmonary fibrosis via modulating p53/PAI-1 pathway;European Journal of Pharmacology;2024-10

2. Sumatriptan mitigates bleomycin-induced lung fibrosis in male rats: Involvement of inflammation, oxidative stress and α-SMA;Tissue and Cell;2024-06

3. Berberine hydrochloride ameliorates PM2.5-induced pulmonary fibrosis in mice through inhibiting oxidative stress and inflammatory;Chemico-Biological Interactions;2023-12

4. Berberine: An inspiring resource for the treatment of colorectal diseases;Biomedicine & Pharmacotherapy;2023-11

5. Insights on the mechanism of bleomycin to induce lung injury and associated in vivo models: A review;International Immunopharmacology;2023-08